BAG3 regulates Rab35 and the ESCRT/endolysosome pathway
BAG3 调节 Rab35 和 ESCRT/内溶酶体途径
基本信息
- 批准号:10667539
- 负责人:
- 金额:$ 43.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-15 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AftercareAlzheimer&aposs DiseaseAreaAutophagocytosisAwarenessBCL2 geneBindingClientDNA cassetteDataDendritic SpinesDevelopmentDiseaseEndosomesEnterobacteria phage P1 Cre recombinaseEstersEventFunctional disorderGTPase-Activating ProteinsHealthHomeostasisInjectionsInvestigationKineticsLeucineLoxP-flanked alleleLysosomesMaintenanceMediatingMediatorMolecularMorphologyMusNeurodegenerative DisordersNeuronsOutcomePathogenesisPathologicPathologyPathway interactionsPatternPhysiological ProcessesPlayPopulationProcessProteinsProteomeProteomicsQuality ControlReactive Oxygen SpeciesRegulationReportingResistanceRoleSignal TransductionSortingStressStructureSynapsesSystemTamoxifenTertiary Protein StructureTestingVesiclehigh resolution imagingin vivoinnovationinsightlive cell imagingmouse modelnoveloptogeneticsoverexpressionpromoterprotein aggregationproteostasisrecruitrepairedtau Proteinstau aggregationtau expressiontau-1trafficking
项目摘要
Protein quality control systems are essential for maintaining neuronal health, with vacuolar dependent pathways
playing a primary role in these systems. The endolysosome system is a major contributor to the maintenance of
the neuronal proteome, and dysfunction of this system occurs early in the pathogenesis of Alzheimer’s disease
(AD) , and likely contributes to the accumulation and mislocalization of tau, which plays a key role in disease
pathogenesis. Recent data provide compelling evidence that the stress responsive, multi-domain protein, Bcl-2-
associated anthogene 3 (BAG3) plays a role in maintaining protein homeostasis and neuronal health. The
expression of BAG3 in specific neuronal populations positively correlates with resistance to the development of
tau pathology in AD. Further, our preliminary data indicate that BAG3 is an upstream regulator of vacuolar
dependent pathways. The UNDERLYING PREMISE of this proposal is that in neurons, BAG3 plays a critical
role in mediating vacuolar dependent pathways, and thus proteostasis and neuronal integrity. The importance
of BAG3 in mediating proteostasis is illustrated by the fact that BAG3 not only plays an important role in protecting
neurons from the accumulation of pathological tau species, but also likely supports synaptic structure.
Nonetheless, our understanding of the mechanisms by which BAG3 regulates vacuolar dependent processes is
very limited. Although previous studies have implicated BAG3 as a mediator of autophagy, we are the first to
present evidence that BAG3 is a regulator of the endolysosome pathway. Further, our preliminary findings
implicate BAG3 as an important modulator of endosomal sorting required for transport (ESCRT) machinery.
BAG3 interacts withTBC1D10B, the primary GTPase activating protein (GAP) for Rab35, which facilitates the
recruitment of the ESCRT machinery and protein clients to the endosome, as well as mediating other vacuolar
dependent processes. The conceptual framework that BAG3 acts upstream of vacuolar pathways through its
regulation of Rab35 activity is novel and innovative. The OVERALL HYPOTHESIS of this proposal is that the
BAG3-TBC1D10B-Rab35 signaling axis regulates endosome-lysosome function and neuronal health. In
the context of this overall hypothesis the specific aims of this proposal are: to test the hypotheses that: (1) the
BAG3-TBC1D10B-Rab35 signaling axis regulates ESCRT and the endolysosome pathway, (2) in vivo BAG3
and Rab35 coordinate to mediate neuronal ESCRT/vacuolar processes, and contribute to the maintenance
synaptic integrity, and (3) the BAG3-TBC1D10B-Rab35 axis plays a critical role in regulating the clearance of
pathological tau species. These studies will be carried out using mouse models and primary neuron cultures.
The IMPACT of these studies is that they will provide crucial new insights into the mechanisms by which BAG3
acts as an upstream mediator of the endolysosome systems to maintain a healthy neuron. Overall these studies
represent a new, unexplored area of investigation that will increase our understanding of the factors that are
essential to maintain a healthy, functional neuronal proteome.
蛋白质质量控制系统对于维持神经元健康至关重
在这些系统中起主要作用。内溶性系统是维护的主要贡献者
该系统的神经元蛋白质组和功能障碍发生在阿尔茨海默氏病的发病机理早期
(AD),并且可能有助于TAU的积累和错误定位,这在疾病中起着关键作用
发病。最近的数据提供了令人信服的证据,表明应激响应性,多域蛋白Bcl-2--
相关的粮仓3(BAG3)在维持蛋白质稳态和神经元健康方面发挥了作用。这
BAG3在特定神经元种群中的表达与对发展的抗性
AD中的Tau病理学。此外,我们的初步数据表明BAG3是真空液的上游调节器
依赖途径。该提议的基本前提是,在神经元中,Bag3扮演着关键
在介导液压依赖途径的作用,从而在蛋白质上和神经元完整性。重要性
Bag3不仅在保护中起着重要作用来说明介导蛋白抑制性的Bag3
病理性tau物种的积累的神经元,但也可能支持合成结构。
但是,我们对BAG3调节真空依赖性过程的机制的理解是
非常有限。尽管以前的研究已经实施了Bag3作为自噬的调解人,但我们是第一个
目前的证据表明BAG3是内溶血途径的调节剂。此外,我们的初步发现
暗示BAG3是运输(ESCRT)机械所需的内体分类的重要调节器。
BAG3与TBC1D10B相互作用,TBC1D10B是Rab35的主要GTPase激活蛋白(GAP),它托有
将ESCRT机械和蛋白质客户招募到内体,并介导其他真空
依赖过程。 Bag3通过其上游的概念框架通过其上游
RAB35活性的调节是新颖而创新的。该提议的总体假设是
BAG3-TBC1D10B-RAB35信号轴调节内体 - 散糖体功能和神经元健康。在
该提案的特定目的是:测试:(1)
BAG3-TBC1D10B-RAB35信号轴调节ESCRT和内溶性途径,(2)体内Bag3
Rab35协调以介导神经元的ESCRT/液泡过程,并有助于维护
突触完整性,(3)BAG3-TBC1D10B-RAB35轴在调节清除率中起着至关重要的作用
病理性的tau物种。这些研究将使用小鼠模型和原发性神经元培养。
这些研究的影响是,它们将对Bag3的机制提供至关重要的新见解。
充当内溶性系统的上游介质,以维持健康的神经元。总体而言,这些研究
代表一个新的,意外的投资领域,这将增加我们对因素的理解
维持健康的功能性神经元蛋白质组至关重要。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The role of BAG3 in health and disease: A "Magic BAG of Tricks".
- DOI:10.1002/jcb.29952
- 发表时间:2022-01
- 期刊:
- 影响因子:4
- 作者:Lin H;Koren SA;Cvetojevic G;Girardi P;Johnson GVW
- 通讯作者:Johnson GVW
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gail V. W. Johnson其他文献
Glycogen Synthase Kinase 3β Phosphorylates Tau at Both Primed and Unprimed Sites
糖原合酶激酶 3β 在引发和未引发的位点磷酸化 Tau
- DOI:
- 发表时间:
2003 - 期刊:
- 影响因子:4.8
- 作者:
Jae;Gail V. W. Johnson - 通讯作者:
Gail V. W. Johnson
Metal-catalyzed oxidation of bovine neurofilaments in vitro.
牛神经丝的体外金属催化氧化。
- DOI:
- 发表时间:
1995 - 期刊:
- 影响因子:7.4
- 作者:
Juan C. Troncoso;Anthony C. Costello;James H. Kim;Gail V. W. Johnson - 通讯作者:
Gail V. W. Johnson
Gail V. W. Johnson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gail V. W. Johnson', 18)}}的其他基金
Mitochondrial dysfunction and tau pathology in Alzheimer's disease
阿尔茨海默病中的线粒体功能障碍和 tau 病理学
- 批准号:
10805120 - 财政年份:2023
- 资助金额:
$ 43.63万 - 项目类别:
Mechanisms of Transglutaminase 2 (TG2)-Mediated Gene Expression in Astrocyte
星形胶质细胞中转谷氨酰胺酶 2 (TG2) 介导的基因表达机制
- 批准号:
10293984 - 财政年份:2021
- 资助金额:
$ 43.63万 - 项目类别:
BAG3 regulates Rab35 and the ESCRT/endolysosome pathway
BAG3 调节 Rab35 和 ESCRT/内溶酶体途径
- 批准号:
10269305 - 财政年份:2021
- 资助金额:
$ 43.63万 - 项目类别:
BAG3 regulates Rab35 and the ESCRT/endolysosome pathway
BAG3 调节 Rab35 和 ESCRT/内溶酶体途径
- 批准号:
10461933 - 财政年份:2021
- 资助金额:
$ 43.63万 - 项目类别:
Tau Post-Translational Modifications and Mitochondrial Quality Control
Tau 翻译后修饰和线粒体质量控制
- 批准号:
10374933 - 财政年份:2020
- 资助金额:
$ 43.63万 - 项目类别:
Tau Post-Translational Modifications and Mitochondrial Quality Control
Tau 翻译后修饰和线粒体质量控制
- 批准号:
10188394 - 财政年份:2020
- 资助金额:
$ 43.63万 - 项目类别:
Tau Post-Translational Modifications and Mitochondrial Quality Control
Tau 翻译后修饰和线粒体质量控制
- 批准号:
10601125 - 财政年份:2020
- 资助金额:
$ 43.63万 - 项目类别:
Tau protein turnover and mitochondrial stress responses
Tau 蛋白周转和线粒体应激反应
- 批准号:
9761421 - 财政年份:2018
- 资助金额:
$ 43.63万 - 项目类别:
相似海外基金
Characterizing Entorhinal Cortex Circuit Dysfunction in an APOE Mouse Model of Chemotherapy-Induced Cognitive Impairment
化疗引起认知障碍的 APOE 小鼠模型中内嗅皮层回路功能障碍的特征
- 批准号:
10677984 - 财政年份:2023
- 资助金额:
$ 43.63万 - 项目类别:
Behavioral Interventions for the Treatment of Early Onset Alzheimer's Disease
治疗早发性阿尔茨海默病的行为干预措施
- 批准号:
10571346 - 财政年份:2023
- 资助金额:
$ 43.63万 - 项目类别:
MIND Foods and Aerobic Training in Black Adults with HTN: An ADRD Prevention Pilot RCT (MAT)
MIND 食品和患有 HTN 的黑人成人的有氧训练:ADRD 预防试点随机对照试验 (MAT)
- 批准号:
10585366 - 财政年份:2023
- 资助金额:
$ 43.63万 - 项目类别:
Healthcare use among older adults with dementia after large-scale disasters
大规模灾难后患有痴呆症的老年人的医疗保健使用情况
- 批准号:
10591812 - 财政年份:2023
- 资助金额:
$ 43.63万 - 项目类别:
Reduced Alzheimer's disease progression and neutrophil adhesion via competition using neutrophil-derived or engineered nanoparticles
通过使用中性粒细胞衍生的或工程化的纳米颗粒竞争,减少阿尔茨海默病的进展和中性粒细胞粘附
- 批准号:
10799111 - 财政年份:2023
- 资助金额:
$ 43.63万 - 项目类别: